PureTech Health (PRTC) Other Accumulated Expenses (2020 - 2025)
PureTech Health (PRTC) reported Other Accumulated Expenses of $4.8 million for Q4 2025, up 31.14% year-over-year from $3.7 million in Q4 2024, and up 31.14% on a QoQ basis from $3.7 million in Q4 2024.
PureTech Health (PRTC) has 6 years of Other Accumulated Expenses data on file, last reported at $4.8 million in Q4 2025.
- Quarterly Other Accumulated Expenses rose 31.14% year-over-year to $4.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.8 million (up 31.14% YoY) and the FY2025 annual result came in at $4.8 million, up 31.14% from the prior year.
- Other Accumulated Expenses improved to $4.8 million in Q4 2025 per PRTC's latest filing, from $3.7 million in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $12.4 million in Q4 2022 and bottomed at $3.4 million in Q4 2023.
- The 5-year median for Other Accumulated Expenses is $4.8 million (2025), against an average of $5.8 million.
- The widest annual swing landed in 2022, when Other Accumulated Expenses jumped 150.98%; it then plunged 72.56% in 2023.
- Tracing PRTC's Other Accumulated Expenses over 5 years: stood at $4.9 million in 2021, then soared by 150.98% to $12.4 million in 2022, then sank by 72.56% to $3.4 million in 2023, then climbed by 7.66% to $3.7 million in 2024, then soared by 31.14% to $4.8 million in 2025.
- Per Business Quant, the three latest PRTC Other Accumulated Expenses figures stand at $4.8 million (Q4 2025), $3.7 million (Q4 2024), and $3.4 million (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.79 Mn |
| Dec 31, 2024 | 3.65 Mn |
| Dec 31, 2023 | 3.39 Mn |
| Dec 31, 2022 | 12.37 Mn |
| Dec 31, 2021 | 4.93 Mn |
| Dec 31, 2020 | 6.72 Mn |